PreciseDx
Dr. Zeineh is a co-founder and currently Chief Technology Officer of PreciseDx, where he brings deep expertise in microscopy technology research and development. Prior to his role at PreciseDx, Dr. Zeineh held a number of technology leadership positions, including CSO for Clarient, CTO/CSO for Carl Zeiss Microimaging AIS, CIO for Aureon Biosciences, and co-founder of Trestle Corporation. Dr. Zeineh graduated Summa Cum Laude from the University of California at Irvine in Biological Sciences and received his medical degree from the University of California at San Diego. He is also a prolific inventor and holds more than 30 patents and patent applications.
This person is not in any offices
PreciseDx
PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology features, enabling better and more personalized treatment and outcomes.